MedMen Revenue and Competitors

Location

$499M

Total Funding

Cannabis

Industry

Estimated Revenue & Valuation

  • MedMen's estimated annual revenue is currently $193.7M per year.(i)
  • MedMen received $250.0M in venture funding in March 2019.
  • MedMen's estimated revenue per employee is $342,900
  • MedMen's total funding is $499M.
  • MedMen's current valuation is $1.5B. (Mar 2019)

Employee Data

  • MedMen has 565 Employees.(i)
  • MedMen grew their employee count by -2% last year.

MedMen's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Head RetailReveal Email/Phone
3
SVP, Technology OperationsReveal Email/Phone
4
VP Equity Comp, Investor Relations & FP&AReveal Email/Phone
5
VP Field OperationsReveal Email/Phone
6
Store DirectorReveal Email/Phone
7
Assistant Store Director OperationsReveal Email/Phone
8
Assistant Store DirectorReveal Email/Phone
9
National Director Compliance and SecurityReveal Email/Phone
10
Director Accounting and Financial ReportingReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$300M24803%$560.5MN/A
#2
$22.7M10135%$60.7MN/A
Add Company

What Is MedMen?

MedMen Enterprises is the United States' preeminent cannabis company with multiple assets and operations in California, Nevada and New York. Combined, these key strategic states account for nearly half of North America's addressable legal market. MedMen owns and operates licensed cannabis facilities in cultivation, manufacturing and retail, and is the most recognized cannabis brand in the world today. MedMen brings class leading operational expertise and unprecedented investment to the fast changing and fast-growing cannabis industry as it moves from its gray market legacy to a fully regulated, legitimate and commercially viable market. Based in Los Angeles, MedMen employs nearly 800 workers across the U.S. It was founded in 2010 by Adam Bierman and Andrew Modlin, two visionary entrepreneurs who saw not just a tremendous business opportunity in the growing legalization of marijuana, but a chance to re-define our society's relationship with cannabis. The federal prohibition has had a disastrous impact, overpopulating our prisons and enriching violent drug cartels while keeping a relatively benign substance with proven benefits out of the reach of law abiding citizens. MedMen supports sensible, clear and just drug laws that strengthen communities and create economic opportunities. The company is the single largest financial supporter of progressive marijuana laws at the local, state and federal levels, giving directly to pro-legalization groups, industry organizations and political candidates. For more information, visit http://www.medmen.com

keywords:N/A

$499M

Total Funding

565

Number of Employees

$193.7M

Revenue (est)

-2%

Employee Growth %

$1.5B

Valuation

N/A

Accelerator

MedMen News

2022-04-19 - Tilray Stock: 3 Catalysts We're Waiting For

Tilray also partially acquired MedMen, which has strong penetration in the U.S. cannabis retail market. According to CEO Irwin Simon,...

2022-04-17 - MedMen: Blowing Away the Purple Haze

MedMen is an MSO with incredible value on the public markets. · Retail operations have class and cash flow. · Earnings will sustain Medmen moving...

2022-04-13 - MedMen: Down, But Not Out

One of MedMen Enterprises' 31 cannabis stores; the company is looking to expand in Massachusetts, Illinois, Arizona and California.

2021-08-21 - MedMen Enterprises : Announces Backstopped US$100M Equity Investment Led by Serruya Private Equity to Fund Expansion and Transform Balance Sheet (Form 8-K)

MedMen Announces Backstopped US$100M Equity Investment Led by Serruya Private Equity to Fund Expansion and Transform Balance Sheet LOS ANGELES - August 17, 2021 -- (BUSINESS WIRE) - MedMen Enterprises Inc. ('MedMen' or the 'Company') (CSE: MMEN) (OTCQX: MMNFF), a premier U.S. cannabis retaile ...

2021-08-17 - MedMen Enterprises : Announces Backstopped US$100M Equity Investment Led by Serruya Private Equity to Fund Expansion and Transform Balance Sheet

MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier U.S. cannabis retailer, today announced that investors, led by Serruya Private Equity ("SPE"), are purchasing US$100 million of units ("Units") of Medmen at a purchase price of US$0.24 (C$0.32) per Unit (th ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$147M58258%N/A
#2
$167M58619%N/A
#3
$104.7M58828%$450M
#4
$186.3M59628%N/A
#5
$222.9M6501%$85.5M

MedMen Funding

DateAmountRoundLead InvestorsReference
2016-04-20$15.0MUndisclosedCap-Meridian VenturesArticle
2017-01-18$30.0MUndisclosedWicklow CapitalArticle
2017-06-14$60.0MUndisclosedMultipleArticle
2018-10-02$73.7MUndisclosedArticle
2018-10-05$100.0MUndisclosedArticle
2019-03-25$250.0MUndisclosedGotham Green PartnersArticle